Despite recent turmoil at FDA, White House praises the agency’s leader
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.
The FDA’s rodent problem worsened during the pandemic, forcing the agency to assign some employees returning to the campus after two years to temporary desks and ask others to continue to telework.